A detailed history of Birchbrook, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Birchbrook, Inc. holds 5,024 shares of JNJ stock, worth $786,004. This represents 0.47% of its overall portfolio holdings.

Number of Shares
5,024
Previous 5,399 6.95%
Holding current value
$786,004
Previous $781 Million 6.71%
% of portfolio
0.47%
Previous 0.44%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Jun 10, 2025

SELL
$142.06 - $167.7 $53,272 - $62,887
-375 Reduced 6.95%
5,024 $833 Million
Q4 2024

Jun 10, 2025

BUY
$143.34 - $165.86 $28,668 - $33,172
200 Added 3.85%
5,399 $781 Million
Q2 2024

Jun 10, 2025

SELL
$144.38 - $157.78 $721 - $788
-5 Reduced 0.1%
5,199 $760 Million
Q1 2024

Jun 10, 2025

SELL
$155.22 - $162.74 $776 - $813
-5 Reduced 0.1%
5,204 $823 Million
Q4 2023

Jun 10, 2025

BUY
$145.6 - $158.88 $758,430 - $827,605
5,209 New
5,209 $817 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $409B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Birchbrook, Inc. Portfolio

Follow Birchbrook, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchbrook, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Birchbrook, Inc. with notifications on news.